secwatch.observer — SEC 8-K summary
======================================

Issuer:     Allarity Therapeutics, Inc. (ALLR)
CIK:        0001860657
Form:       8-K/A
Filed at:   2024-09-10T23:59:59+00:00
Accession:  0001213900-24-077144
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 3.03, 5.03, 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Allarity Therapeutics corrects reverse stock split effective time to Sept 11, 2024
--------------------------------------------------------------------------------

- Certificate of Correction filed to set 1-for-30 reverse split effective 12:01 a.m. ET Sept 11, 2024.
- Charter amendment reduces authorized shares from 750.5M to 250.5M, effective Sept 9 at 9:30 a.m. ET.
- 2021 Equity Incentive Plan shares increased from 2,168,330 to 10,594,876 approved at Annual Meeting.
- All 7 stockholder proposals passed at Sept 3 Annual Meeting, including director elections and auditor ratification.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860657/000121390024077144/0001213900-24-077144-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860657/000121390024077144/ea0214018-8ka1_allarity.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-077144

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer